185 related articles for article (PubMed ID: 27220233)
21. Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa.
Fishman GA; Apushkin MA
Br J Ophthalmol; 2007 Jun; 91(6):743-5. PubMed ID: 17215269
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome.
Genead MA; Fishman GA
Arch Ophthalmol; 2010 Sep; 128(9):1146-50. PubMed ID: 20837798
[TBL] [Abstract][Full Text] [Related]
23. The effect of an intravitreal dexamethasone implant for cystoid macular edema in retinitis pigmentosa: a case report and literature review.
Ahn SJ; Kim KE; Woo SJ; Park KH
Ophthalmic Surg Lasers Imaging Retina; 2014; 45(2):160-4. PubMed ID: 24506098
[TBL] [Abstract][Full Text] [Related]
24. Retinitis pigmentosa sine pigmenti. Debut with macular oedema.
de la Mata Pérez G; Ruiz-Moreno O; Fernández-Pérez S; Torrón Fernández-Blanco C; Pablo-Júlvez L
Arch Soc Esp Oftalmol; 2014 Sep; 89(9):376-81. PubMed ID: 24485789
[TBL] [Abstract][Full Text] [Related]
25. EFFECT OF ORAL CARBONIC ANHYDRASE INHIBITOR ON CYSTOID MACULAR EDEMA ASSOCIATED WITH RETINITIS PIGMENTOSA: An OCT and OCT Angiography Study.
Yeo JH; Min CH; Yoon YH
Retina; 2022 Sep; 42(9):1796-1804. PubMed ID: 35617678
[TBL] [Abstract][Full Text] [Related]
26. The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination.
Hajali M; Fishman GA
Eye (Lond); 2009 Apr; 23(4):915-9. PubMed ID: 18425064
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation confirms MFRP as the gene causing the syndrome of nanophthalmos-renititis pigmentosa-foveoschisis-optic disk drusen.
Crespí J; Buil JA; Bassaganyas F; Vela-Segarra JI; Díaz-Cascajosa J; Ayala-Ramírez R; Zenteno JC
Am J Ophthalmol; 2008 Aug; 146(2):323-328. PubMed ID: 18554571
[TBL] [Abstract][Full Text] [Related]
28. A new autosomal recessive syndrome consisting of posterior microphthalmos, retinitis pigmentosa, foveoschisis, and optic disc drusen is caused by a MFRP gene mutation.
Ayala-Ramirez R; Graue-Wiechers F; Robredo V; Amato-Almanza M; Horta-Diez I; Zenteno JC
Mol Vis; 2006 Dec; 12():1483-9. PubMed ID: 17167404
[TBL] [Abstract][Full Text] [Related]
29. Eplerenone, a new treatment for an old problem: Retinitis pigmentosa with recalcitrant macular edema.
Campos Polo R; Rubio Sánchez C; García Guisado DM; Díaz Luque MJ
Arch Soc Esp Oftalmol (Engl Ed); 2018 Jan; 93(1):38-41. PubMed ID: 28624313
[TBL] [Abstract][Full Text] [Related]
30. Treatment of cystoid macular edema related to retinitis pigmentosa with intravitreal triamcinolone acetonide.
Saraiva VS; Sallum JM; Farah ME
Ophthalmic Surg Lasers Imaging; 2003; 34(5):398-400. PubMed ID: 14509465
[TBL] [Abstract][Full Text] [Related]
31. Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher's syndrome.
Lemos Reis RF; Moreira-Gonçalves N; Estrela Silva SE; Brandão EM; Falcão-Reis FM
Ophthalmologica; 2015; 233(1):43-50. PubMed ID: 25428176
[TBL] [Abstract][Full Text] [Related]
32. Cystic macular lesions in patients with retinitis pigmentosa.
Ganesh A; Manayath G; Al-Senawi R; Ok S; Al-Zuhaibi S
Arch Ophthalmol; 2011 Jun; 129(6):817; author reply 817-8. PubMed ID: 21670364
[No Abstract] [Full Text] [Related]
33. Choroidal vascular index in cystoid macular edema associated with retinitis pigmentosa.
Marino AV; De Luca M; Gioia M
Photodiagnosis Photodyn Ther; 2023 Sep; 43():103623. PubMed ID: 37211298
[No Abstract] [Full Text] [Related]
34. Intravitreal ranibizumab in the treatment of cystoid macular edema associated with retinitis pigmentosa.
Artunay O; Yuzbasioglu E; Rasier R; Sengul A; Bahcecioglu H
J Ocul Pharmacol Ther; 2009 Dec; 25(6):545-50. PubMed ID: 20028262
[TBL] [Abstract][Full Text] [Related]
35. MFRP-Related Nanophthalmos-Retinitis Pigmentosa-Foveoschisis-Optic Disc Drusen Syndrome.
Marques JP
Ophthalmic Surg Lasers Imaging Retina; 2021 Feb; 52(2):110. PubMed ID: 33626173
[TBL] [Abstract][Full Text] [Related]
36. Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa.
Apushkin MA; Fishman GA; Grover S; Janowicz MJ
Retina; 2007 Oct; 27(8):1112-8. PubMed ID: 18040255
[TBL] [Abstract][Full Text] [Related]
37. Photoreceptor integrity and visual acuity in cystoid macular oedema associated with retinitis pigmentosa.
Oishi A; Otani A; Sasahara M; Kojima H; Nakamura H; Kurimoto M; Yoshimura N
Eye (Lond); 2009 Jun; 23(6):1411-6. PubMed ID: 18724276
[TBL] [Abstract][Full Text] [Related]
38. The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema.
Moldow B; Sander B; Larsen M; Engler C; Li B; Rosenberg T; Lund-Andersen H
Graefes Arch Clin Exp Ophthalmol; 1998 Dec; 236(12):881-9. PubMed ID: 9865617
[TBL] [Abstract][Full Text] [Related]
39. Intravitreal triamcinolone acetonide for treatment of cystoid macular edema associated with retinitis pigmentosa.
Kim JE
Retina; 2006; 26(9):1094-6. PubMed ID: 17151506
[No Abstract] [Full Text] [Related]
40. Frequency of optic disc or parapapillary nerve fiber layer drusen in retinitis pigmentosa.
Grover S; Fishman GA; Brown J
Ophthalmology; 1997 Feb; 104(2):295-8. PubMed ID: 9052635
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
